Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

A Phase 1 trial in pediatric patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes evaluated a monoclonal antibody in combina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Monoclonal antibody (combination therapy)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED